This overview page provides a quick summary of the selected assets, including their latest prices, price changes, market capitalization changes, and more.
This page just gave you an overview, you might also want to check out the comprehensive stats, historical, correlation, volatility, and price projection pages.
Allurion Technologies Inc. operates within the medical device industry, specifically focusing on weight management solutions. The company has developed a novel, swallowable, and non-surgical intragastric balloon system designed for individuals seeking to lose weight. This innovative approach aims to provide a less invasive and more accessible alternative to traditional bariatric surgery or endoscopic procedures. The core product is the Elipse Balloon, a capsule that, once swallowed, inflates in the stomach to promote feelings of fullness and reduce food intake. After approximately four months, the balloon naturally deflates and is passed from the body. Allurion's strategy often involves integrating this device with a comprehensive lifestyle coaching program, emphasizing a holistic approach to weight loss and long-term health. The company targets a significant global market of individuals struggling with obesity and overweight conditions, positioning itself as a disruptor in the medical weight loss sector.
Read moreThis website uses cookies for essential functions, other functions, and for statistical purposes. Please refer to the cookie policy for details.
This feature requires functional cookies. Please refer to the cookie policy for details.
We sent you a verification email. Copy and paste the verification code above.
Trade hundreds of crypto perpetual futures